2017
DOI: 10.1016/j.transproceed.2017.02.028
|View full text |Cite
|
Sign up to set email alerts
|

Carbapenem-Resistant Klebsiella Pneumoniae Infections Early After Liver Transplantation: A Single-Center Experience

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
21
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 22 publications
(23 citation statements)
references
References 10 publications
1
21
0
Order By: Relevance
“…In sensitivity analysis, excluding two studies [31,42] with an unclear risk of bias (Additional Table 6), the analysis still found a significantly increased risk of mortality among patients with CR infections compared to controls (summary OR: (Table 2). Additional subgroup meta-analysis of unadjusted mortality data at different time points similarly found a significantly higher risk of mortality in patients with CR infections than in controls: in-hospital/≤30-day mortality (4 studies [13,32,40,45]; summary OR: 6.08; 95% CI: 3.83, 9.66; I 2 = 0.0%) and longer follow-up (greater than 6 months) (5 studies [31,37,38,40,42]; summary OR: 6.56; 95% CI: 2.81, 15.33; I 2 = 51.3%) ( Table 2). Meta-analysis of the five studies that also reported multivariable data [31,37,38,40,45] (adjusted for various confounders (Additional Table 5)) compared 239 patients with CR infections to 1097 controls and found a significantly increased risk of mortality (summary HR: 4.67; 95% CI: 2.18, 9.99; I 2 = 77.7%) (Fig.…”
Section: Meta-analysis Of Mortality Data From Studies Of Totally Highmentioning
confidence: 99%
See 3 more Smart Citations
“…In sensitivity analysis, excluding two studies [31,42] with an unclear risk of bias (Additional Table 6), the analysis still found a significantly increased risk of mortality among patients with CR infections compared to controls (summary OR: (Table 2). Additional subgroup meta-analysis of unadjusted mortality data at different time points similarly found a significantly higher risk of mortality in patients with CR infections than in controls: in-hospital/≤30-day mortality (4 studies [13,32,40,45]; summary OR: 6.08; 95% CI: 3.83, 9.66; I 2 = 0.0%) and longer follow-up (greater than 6 months) (5 studies [31,37,38,40,42]; summary OR: 6.56; 95% CI: 2.81, 15.33; I 2 = 51.3%) ( Table 2). Meta-analysis of the five studies that also reported multivariable data [31,37,38,40,45] (adjusted for various confounders (Additional Table 5)) compared 239 patients with CR infections to 1097 controls and found a significantly increased risk of mortality (summary HR: 4.67; 95% CI: 2.18, 9.99; I 2 = 77.7%) (Fig.…”
Section: Meta-analysis Of Mortality Data From Studies Of Totally Highmentioning
confidence: 99%
“…Twenty-five studies reported mortality in patients with CR infections [13,[22][23][24][25][26][27][28][29][30][31][32][34][35][36][37][38][39][40][41][42][43][44][45][46]. Of these, 12 compared mortality in patients with CR infections with mortality in patients without a CR infection (e.g., CS infection, no CR infection, no infection), which permitted the calculation of unadjusted ORs [13, 22, 27-30, 32, 36-38, 42, 45], 11 provided results for patients with CR infection only [23-26, 34, 35, 39, 41, 43, 44, 46], and two [31,40] reported 30-day mortality for patients with CR infection only and either 6-month or 1-year mortality for both patients with CR infection and patients with no CR infection.…”
Section: Mortalitymentioning
confidence: 99%
See 2 more Smart Citations
“…Most of current antibiotics utilized in practice have no therapeutic effect on CRKP infection after renal transplantation, with the mortality can be as high as 40% to 70% [55,56], and the 30-days mortality rate was 50% to 60% [57,58]. In recent years, the resistance rate of CRKP to polymyxin and tigecycline was increasing [59,60].…”
Section: Discussionmentioning
confidence: 99%